Abbott Labs (ABT) ebitda was $10.2B in FY2025 (+15% YoY). The tables below show the complete quarterly and annual ebitda history, sourced from SEC EDGAR 10-K and 10-Q filings.
Annual EBITDA
Fiscal Year
EBITDA
YoY
2025
$10.2B
+15%
2024
$8.8B
+5%
2023
$8.4B
-18%
2022
$10.3B
-2%
2021
$10.6B
+48%
2020
$7.1B
+15%
2019
$6.2B
+18%
2018
$5.3B
+74%
2017
$3.0B
-25%
2016
$4.0B
-0%
2015
$4.0B
+7%
2014
$3.8B
+7%
2013
$3.5B
-1%
2012
$3.6B
+4%
2011
$3.4B
-56%
2010
$7.7B
-2%
2009
$7.9B
+11%
2008
$7.1B
+17%
2007
$6.1B
Recent Quarterly EBITDA
Quarter
EBITDA
Q1 2026
$2.0B
Q4 2025
$2.7B
Q3 2025
$2.5B
Q2 2025
$2.6B
Q1 2025
$2.3B
Q4 2024
$2.4B
Q3 2024
$2.3B
Q2 2024
$2.1B
Q1 2024
$2.0B
Q4 2023
$1.9B
Q3 2023
$2.3B
Q2 2023
$2.2B
Source: ABT on EDGAR. Data from SEC EDGAR 10-K and 10-Q filings. Updated quarterly.